Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...

Walgreens is a 2,500lb great white in the global healthcare system, but the stock is a minnow. The U.S. Pharmacy business is structurally broken, but the reimbursement model is set for a major change ...

Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable prescription drugs. Starjemza® ...

The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...

MADISON, Wis.--(BUSINESS WIRE)--Lumicera Health Services, the first specialty pharmacy built on a cost-plus model, is celebrating 10 years of making specialty medication pricing more transparent and ...

HONEY BROOK, Pa., March 12, 2024 /PRNewswire/ -- Provell Pharmaceuticals, a healthcare company that distributes world-class, branded drugs at generic prices by eliminating middlemen markups, today ...

One of the largest pharmacy benefits managers in the U.S. is overhauling how millions of its commercial members pay for drugs, in a move that should save consumers money at the pharmacy counter while ...

Sunny Kaila wants to help MSPs remain competitive. “Our focus will be on helping MSPs adopt boundary-less thinking and leverage our cost-plus model to enhance their capabilities,” Kaila, CEO of ...